位置:首页 > 蛋白库 > ARNB_SALTY
ARNB_SALTY
ID   ARNB_SALTY              Reviewed;         385 AA.
AC   Q8ZNF3; O52323;
DT   21-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2016, sequence version 3.
DT   03-AUG-2022, entry version 130.
DE   RecName: Full=UDP-4-amino-4-deoxy-L-arabinose--oxoglutarate aminotransferase;
DE            EC=2.6.1.87 {ECO:0000269|PubMed:12429098};
DE   AltName: Full=Polymyxin resistance protein PmrH;
DE   AltName: Full=UDP-(beta-L-threo-pentapyranosyl-4''-ulose diphosphate) aminotransferase;
DE            Short=UDP-Ara4O aminotransferase;
DE   AltName: Full=UDP-4-amino-4-deoxy-L-arabinose aminotransferase;
GN   Name=arnB; Synonyms=pbgP, pbgP1, pmrH; OrderedLocusNames=STM2297;
OS   Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Salmonella.
OX   NCBI_TaxID=99287;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 14028s / SGSG 2262;
RX   PubMed=9570402; DOI=10.1046/j.1365-2958.1998.00757.x;
RA   Gunn J.S., Lim K.B., Krueger J., Kim K., Guo L., Hackett M., Miller S.I.;
RT   "PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A
RT   modification and polymyxin resistance.";
RL   Mol. Microbiol. 27:1171-1182(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=LT2 / SGSC1412 / ATCC 700720;
RX   PubMed=11677609; DOI=10.1038/35101614;
RA   McClelland M., Sanderson K.E., Spieth J., Clifton S.W., Latreille P.,
RA   Courtney L., Porwollik S., Ali J., Dante M., Du F., Hou S., Layman D.,
RA   Leonard S., Nguyen C., Scott K., Holmes A., Grewal N., Mulvaney E.,
RA   Ryan E., Sun H., Florea L., Miller W., Stoneking T., Nhan M., Waterston R.,
RA   Wilson R.K.;
RT   "Complete genome sequence of Salmonella enterica serovar Typhimurium LT2.";
RL   Nature 413:852-856(2001).
RN   [3]
RP   INDUCTION.
RC   STRAIN=ATCC 14028s / SGSG 2262;
RX   PubMed=10480935; DOI=10.1074/jbc.274.38.27185;
RA   Woesten M.M.S.M., Groisman E.A.;
RT   "Molecular characterization of the PmrA regulon.";
RL   J. Biol. Chem. 274:27185-27190(1999).
RN   [4] {ECO:0007744|PDB:1MDO, ECO:0007744|PDB:1MDX, ECO:0007744|PDB:1MDZ}
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) IN COMPLEX WITH PYRIDOXAL PHOSPHATE
RP   AND INHIBITOR, FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, ACTIVE
RP   SITE, AND SUBUNIT.
RX   PubMed=12429098; DOI=10.1016/s0969-2126(02)00879-1;
RA   Noland B.W., Newman J.M., Hendle J., Badger J., Christopher J.A.,
RA   Tresser J., Buchanan M.D., Wright T.A., Rutter M.E., Sanderson W.E.,
RA   Mueller-Dieckmann H.-J., Gajiwala K.S., Buchanan S.G.;
RT   "Structural studies of Salmonella typhimurium ArnB (PmrH) aminotransferase:
RT   a 4-amino-4-deoxy-L-arabinose lipopolysaccharide-modifying enzyme.";
RL   Structure 10:1569-1580(2002).
RN   [5] {ECO:0007744|PDB:4OCA}
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF MUTANT ALA-188 IN COMPLEX WITH
RP   PYRIDOXAL PHOSPHATE AND SUBSTRATE, FUNCTION, ACTIVE SITE, REACTION
RP   MECHANISM, SUBUNIT, AND MUTAGENESIS OF LYS-188.
RX   PubMed=24460375; DOI=10.1021/bi4015677;
RA   Lee M., Sousa M.C.;
RT   "Structural basis for substrate specificity in ArnB. A key enzyme in the
RT   polymyxin resistance pathway of Gram-negative bacteria.";
RL   Biochemistry 53:796-805(2014).
CC   -!- FUNCTION: Catalyzes the conversion of UDP-4-keto-arabinose (UDP-Ara4O)
CC       to UDP-4-amino-4-deoxy-L-arabinose (UDP-L-Ara4N) (PubMed:12429098,
CC       PubMed:24460375). The modified arabinose is attached to lipid A and is
CC       required for resistance to polymyxin and cationic antimicrobial
CC       peptides (By similarity). {ECO:0000250, ECO:0000269|PubMed:12429098,
CC       ECO:0000269|PubMed:24460375}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate + UDP-4-amino-4-deoxy-beta-L-arabinose = L-
CC         glutamate + UDP-beta-L-threo-pentopyranos-4-ulose;
CC         Xref=Rhea:RHEA:24710, ChEBI:CHEBI:16810, ChEBI:CHEBI:29985,
CC         ChEBI:CHEBI:58708, ChEBI:CHEBI:58710; EC=2.6.1.87;
CC         Evidence={ECO:0000269|PubMed:12429098};
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000269|PubMed:12429098};
CC   -!- ACTIVITY REGULATION: Inhibited by L-cycloserine.
CC       {ECO:0000269|PubMed:12429098}.
CC   -!- PATHWAY: Nucleotide-sugar biosynthesis; UDP-4-deoxy-4-formamido-beta-L-
CC       arabinose biosynthesis; UDP-4-deoxy-4-formamido-beta-L-arabinose from
CC       UDP-alpha-D-glucuronate: step 2/3.
CC   -!- PATHWAY: Bacterial outer membrane biogenesis; lipopolysaccharide
CC       biosynthesis.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:12429098,
CC       ECO:0000269|PubMed:24460375}.
CC   -!- INDUCTION: Induced by BasR. {ECO:0000269|PubMed:10480935}.
CC   -!- SIMILARITY: Belongs to the DegT/DnrJ/EryC1 family. ArnB subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF036677; AAC04770.1; -; Genomic_DNA.
DR   EMBL; AE006468; AAL21198.1; -; Genomic_DNA.
DR   RefSeq; NP_461239.3; NC_003197.2.
DR   RefSeq; WP_001520579.1; NC_003197.2.
DR   PDB; 1MDO; X-ray; 1.70 A; A=1-385.
DR   PDB; 1MDX; X-ray; 1.96 A; A=1-385.
DR   PDB; 1MDZ; X-ray; 2.07 A; A=1-385.
DR   PDB; 4OCA; X-ray; 2.30 A; A=1-385.
DR   PDBsum; 1MDO; -.
DR   PDBsum; 1MDX; -.
DR   PDBsum; 1MDZ; -.
DR   PDBsum; 4OCA; -.
DR   AlphaFoldDB; Q8ZNF3; -.
DR   SMR; Q8ZNF3; -.
DR   STRING; 99287.STM2297; -.
DR   DrugBank; DB02038; D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide.
DR   DrugBank; DB02142; Pyridoxamine-5'-Phosphate.
DR   PaxDb; Q8ZNF3; -.
DR   EnsemblBacteria; AAL21198; AAL21198; STM2297.
DR   GeneID; 1253819; -.
DR   KEGG; stm:STM2297; -.
DR   HOGENOM; CLU_033332_0_3_6; -.
DR   PhylomeDB; Q8ZNF3; -.
DR   BioCyc; SENT99287:STM2297-MON; -.
DR   UniPathway; UPA00030; -.
DR   UniPathway; UPA00032; UER00493.
DR   EvolutionaryTrace; Q8ZNF3; -.
DR   Proteomes; UP000001014; Chromosome.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IBA:GO_Central.
DR   GO; GO:0008483; F:transaminase activity; IBA:GO_Central.
DR   GO; GO:0099620; F:UDP-4-amino-4-deoxy-L-arabinose aminotransferase; IEA:UniProtKB-EC.
DR   GO; GO:0009245; P:lipid A biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0009103; P:lipopolysaccharide biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0000271; P:polysaccharide biosynthetic process; IBA:GO_Central.
DR   GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW.
DR   CDD; cd00616; AHBA_syn; 1.
DR   Gene3D; 3.40.640.10; -; 1.
DR   Gene3D; 3.90.1150.10; -; 1.
DR   HAMAP; MF_01167; ArnB_transfer; 1.
DR   InterPro; IPR022850; ArnB_NH2Trfase.
DR   InterPro; IPR000653; DegT/StrS_aminotransferase.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_small.
DR   PANTHER; PTHR30244; PTHR30244; 1.
DR   Pfam; PF01041; DegT_DnrJ_EryC1; 1.
DR   PIRSF; PIRSF000390; PLP_StrS; 1.
DR   SUPFAM; SSF53383; SSF53383; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Aminotransferase; Antibiotic resistance;
KW   Lipid A biosynthesis; Lipid biosynthesis; Lipid metabolism;
KW   Lipopolysaccharide biosynthesis; Pyridoxal phosphate; Reference proteome;
KW   Transferase.
FT   CHAIN           1..385
FT                   /note="UDP-4-amino-4-deoxy-L-arabinose--oxoglutarate
FT                   aminotransferase"
FT                   /id="PRO_0000110028"
FT   ACT_SITE        188
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305|PubMed:12429098,
FT                   ECO:0000305|PubMed:24460375"
FT   MOD_RES         188
FT                   /note="N6-(pyridoxal phosphate)lysine"
FT                   /evidence="ECO:0000269|PubMed:12429098,
FT                   ECO:0007744|PDB:1MDX, ECO:0007744|PDB:1MDZ"
FT   MUTAGEN         188
FT                   /note="K->A: Loss of covalent pyridoxal phosphate binding."
FT                   /evidence="ECO:0000269|PubMed:24460375"
FT   CONFLICT        285
FT                   /note="L -> V (in Ref. 2; AAC04770)"
FT                   /evidence="ECO:0000305"
FT   HELIX           20..32
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   STRAND          36..38
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   HELIX           39..52
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   STRAND          55..61
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   HELIX           63..73
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   STRAND          81..88
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   HELIX           90..98
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   STRAND          102..106
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   TURN            110..112
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   HELIX           117..123
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   STRAND          128..131
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   HELIX           136..138
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   HELIX           143..153
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   STRAND          157..160
FT                   /evidence="ECO:0007829|PDB:1MDX"
FT   STRAND          176..183
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   STRAND          188..190
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   STRAND          192..194
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   STRAND          196..201
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   HELIX           203..212
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   STRAND          234..237
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   HELIX           246..257
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   HELIX           259..278
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   STRAND          299..302
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   HELIX           305..308
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   HELIX           312..321
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   HELIX           333..335
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   HELIX           337..342
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   HELIX           349..355
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   STRAND          358..361
FT                   /evidence="ECO:0007829|PDB:1MDO"
FT   HELIX           369..383
FT                   /evidence="ECO:0007829|PDB:1MDO"
SQ   SEQUENCE   385 AA;  41813 MW;  DAA6C24FC591FA05 CRC64;
     MAEGKMMSDF LPFSRPAMGA EELAAVKTVL DSGWITTGPK NQELEAAFCR LTGNQYAVAV
     SSATAGMHIA LMALGIGEGD EVITPSMTWV STLNMIVLLG ANPVMVDVDR DTLMVTPEHI
     EAAITPQTKA IIPVHYAGAP ADLDAIYALG ERYGIPVIED AAHATGTSYK GRHIGARGTA
     IFSFHAIKNI TCAEGGIVVT DNPQFADKLR SLKFHGLGVD AWDRQSGGRA PQAEVLAPGY
     KYNLPDLNAA IALAQLQKLD ALNARRAAIA AQYHQAMADL PFQPLSLPSW EHIHAWHLFI
     IRVDEARCGI TRDALMASLK TKGIGTGLHF RAAHTQKYYR ERFPTLTLPD TEWNSERICS
     LPLFPDMTES DFDRVITALH QIAGQ
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024